Call for Abstract
20th World Congress on Pediatric Oncology and Clinical Pediatrics, will be organized around the theme “Medical and Psychosocial Issues and Strategies Employed to Cure Childhood Cancer”
Pediatric Oncology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pediatric Oncology 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Pediatric oncology is a strength discipline in drug concerned with diagnosing and treating kids, as a rule up to the age of 18, with malignancy. It is thought to be one of the most challenging of specialties because, despite successful treatment of many children, there is a high death rate still connected with different sorts of malignancies. Sorts of Pediatric Oncology incorporate Pediatric Hematology Oncology, Pediatric Leukemia, Neuroblastoma in Children, Brain Tumor in Children, Clinical Trials, Advances in Pediatric Oncology Treatment, Oncology Nursing and Care, Advanced Pediatric Oncology Drugs, Pediatric Radiation Oncology, Pediatric Oncology Diagnostic, Radiotherapy Oncology, Pediatric Neuro-Oncology.
- Track 1-1Focus on translational research
- Track 1-2Attacking brain tumors
- Track 1-3New approaches to sarcoma research
- Track 1-4Advancing our understanding of neuroblastoma
- Track 1-5Genomic approaches to drug discovery
- Track 1-6Harnessing the immune system to fight cancer
- Track 1-7Ewing sarcoma
The aim of the study of pediatrics is to reduce infant and child rate of deaths, control the spread of infectious disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents. It can be acknowledged that this can be reached by learning the major and primary subject on General Pediatrics. General Pediatrics includes the basic treatments involved for the betterment of pediatric health. The most significant problems can be due to nutritional deficiencies to the overall health of infants and children because growth and development can be seriously hindered by shortages in essential vitamins or nutrients.
- Track 2-1Clinical pediatric dentistry
- Track 2-2Clinical pediatric emergency medicine
- Track 2-3Clinical pediatrics nursing
- Track 2-4Clinical pediatrics neurology
- Track 2-5Clinical pediatrics cardiology
- Track 2-6Clinical pediatrics dermatology
- Track 2-7Clinical pediatrics Care
- Track 2-8Clinical pediatrics practices
The most common cancer in children is Leukemia, which is cancers of the bone marrow and blood, are the most common childhood cancers. They account for about 30% of all cancers in children. Brain and central nervous system tumors are the second most common cancers in children, making up about 26% of childhood cancers. Neuroblastoma starts in early forms of nerve cells found in a developing embryo or fetus. About 6% of childhood cancers are neuroblastomas. Wilms tumor starts in one, or rarely, both kidneys. It is most often found in children about 3 to 4 years old. It can show up as a swelling or lump in the belly (abdomen). It accounts for about 5% of childhood cancers. Lymphoma start in certain cells of the immune system called lymphocytes. They most often grow in lymph nodes and other lymph tissues, like the tonsils or thymus. Rhabdomyosarcoma starts in cells that normally develop into skeletal muscles. It makes up about 3% of childhood cancers. Osteosarcoma is most common in teens, and usually develops in areas where the bone is growing quickly, such as near the ends of the long bones in the legs or arms. Ewing sarcoma is a less common type of bone cancer, which can also cause bone pain and swelling. It is most often found in young teens. Germ cell tumors make up about 3% of all childhood cancers. Ninety percent of germ cell tumors are gonadal which are found in the ovaries or testicles and are more common in children and adolescents. Pleuropulmonary blastoma (PPB) is a rare childhood cancer occurring in the chest, specifically in the lungs or in the coverings of the lungs called "pleura". Hepatoblastoma is the most common primary liver tumor in children, accounting for just over 1% of pediatric cancers.
- Track 3-1Leukemia
- Track 3-2Brain tumors
- Track 3-3Neuroblastoma
- Track 3-4Wilms tumor
- Track 3-5Lymphoma
- Track 3-6Rhabdomyosarcoma
- Track 3-7Osteosarcoma
- Track 3-8Ewing sarcoma
- Track 3-9Germ cell tumors
- Track 3-10Pleuropulmonary blastoma
- Track 3-11Hepatoblastoma
Pediatric hematology is the branch of pediatrics dealing with study, diagnosis, treatment and prevention different types of blood disorders including the study of bleeding and clotting disorders in children. The study of Tumor Cell Biology reviews applications concerned with signal transduction mechanisms in neoplastic cells, and regulation of tumor cell phenotype and behaviour, and tumor progression. It important to study causes, risk factors and the hypothesis in pediatrics with hematology disorders. A medical practitioner who specializes in this field of pediatric hematology is called pediatric hematologist. It is important that one should be familiar with the educational and preventive measures in order to prevent children being affected with blood disorders.
- Track 4-1Bleeding and clotting disorders
- Track 4-2Tumor cell biology and research
- Track 4-3Causes, risk factors and hypotheses
- Track 4-4Drug development and diagnostics
- Track 4-5Educational and preventive measures
Leukemia is usually described either as "acute", which grows quickly, or "chronic", which grows slowly. One main type of acute leukemia is acute lymphocytic leukemia (ALL), which accounts for about 3 out of 4 cases of leukemia in children. ALL is a form of leukemia that affects the lymphocytes, a type of white blood cells which fights infection. Another type of acute leukemia is acute myelogenous leukemia (AML). AML is cancer of the blood in which too many myeloblasts, immature white blood cells, are produced in the bone marrow.
Chronic leukemias are more common in adults than in children, and although they tend to grow more slowly than acute leukemias, they are harder to treat. These chronic leukemias are divided into two types: chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL). CML is rare in children, but does occur and is treatable in children the same as in adults. CML patients have too many immature white blood cells being produced, and the cells crowd the other healthy blood cells. Juvenile myelomonocytic leukemia (JMML) is a form of leukemia that is neither chronic nor acute and occurs most often in children under the age of four. JMML begins from myeloid cells, but is not as fast-growing as AML or as slow as CML.
- Track 5-1Acute lymphoblastic leukemia
- Track 5-2Acute myelogenous leukemia
- Track 5-3Chronic myelogenous leukemia
- Track 5-4Chronic lymphocytic leukemia
- Track 5-5Juvenile myelomonocytic leukemia
Intensity-modulated radiation therapy (IMRT), a type of external beam radiation therapy, is the most commonly used approach for pediatric patients. This computer-guided technology can precisely target cancer cells, which reduces the radiation delivered to nearby normal tissue and minimizes side effects. X-rays, CT scanning, MRI scanning, ultrasound and other radiological techniques to localise and guide biopsy. Scintigraphy, Single Photon Emission Computed Tomography (SPECT), Positron emission tomography (PET) and other methods of nuclear medicine to identify areas suspicious for malignancy.
- Track 6-1Radiation oncology
- Track 6-2Advances in cancer detection
- Track 6-3Magnetic resonance imaging
- Track 6-4Ultrasound
- Track 6-5Radiographic testing
- Track 6-6Radiology trends and technology
The management of children with brain and spinal cord tumors is extremely complex. Pediatric brain cancers can be stubborn, and typically do not respond to traditional chemotherapy and radiation. in part because the brain is somewhat protected from medications the blood-brain barrier, in part because surgery in the brain has to be quite refined to minimize injury to brain tissue, and in part because radiation treatment to the brain can cause injury to normal brain tissue.
- Track 7-1Craniopharyngiomas
- Track 7-2Germ cells tumors
- Track 7-3Ependymomas
- Track 7-4Medulloblastomas
- Track 7-5Pineal parenchymal tumors
- Track 7-6Neurofibromatosis
- Track 7-7Neurocutaneous disorders
- Track 7-8Translational therapeutics
The purpose of Diagnostic and Therapeutic Advances in Pediatric Oncology for the Cancer Treatment and Research Series is to provide an up-to-date summary of how recent advances in cancer research are being applied to the care of children with solid tumors. Pediatric diagnostic radiation uses medical imaging to diagnose and treat medical conditions in children.
- Track 8-1Next-gen sequencing for diagnosis and monitoring of cancers
- Track 8-2Advancements in CT scan, MRI scan, mammograms, radiography etc
- Track 8-3Biomarkers in cancer diagnosis and prognosis
- Track 8-4Portable computer-aided detection and diagnostic (CADD) tools
Certain disorders (such as ALL or AML) will require immediate admission and chemotherapy, while others will be followed up with regular physical examination and blood tests. Often, surgery is attempted to remove a tumor entirely. This is only feasible when there is some degree of certainty that the tumor can in fact be removed. Surgery is also used for the palliative treatment of some of cancers, e.g. to relieve biliary obstruction, or to relieve the problems associated with some cerebral tumors. The risks of surgery must be weighed against the benefits. A Bone marrow transplant is a medical procedure in which bone marrow that contains cancer is replaced by highly specialized cells, called hematopoietic stem cells, that develop into healthy bone marrow. Chemotherapy and radiotherapy are used as a first-line radical therapy in a number of malignancies. They are also used for adjuvant therapy, i.e. when the macroscopic tumor has already been completely removed surgically but there is a reasonable statistical risk that it will recur. Chemotherapy and radiotherapy are commonly used for palliation, where disease is clearly incurable. There is currently a rapid expansion in the use of monoclonal antibody treatments, notably for lymphoma (Rituximab), and breast cancer (Trastuzumab). Vaccine and other immunotherapies are the subject of intensive research.
- Track 9-1Surgery
- Track 9-2Chemotherapy
- Track 9-3Radiation
- Track 9-4Bone marrow transplants
- Track 9-5Immunotherapy
- Track 9-6Blood product donation and transfusion
- Track 9-7Monoclonal antibody treatments
- Track 9-8Alternative medical systems
- Track 9-9Mind-body interventions
- Track 9-10Biologically based therapies
- Track 9-11Manipulative and body-based methods
- Track 9-12Energy therapies
It can be frightening to hear that a child has cancer or a blood disorder. It is acknowledged that Neuroblastoma is the most common extracranial solid tumor of infancy. It is an embryonal malignancy of the sympathetic nervous system arising from neuroblasts (pluripotent sympathetic cells). Researchers are looking for genetic source of childhood brain tumors. Their main target is Germ cell tumors (GCTs) in children which are masses of tissue formed by the type of immature cells. Germ cell tumors may be malignant, which means cancerous, or they may be benign, which means noncancerous. The common blood disorders in children are leukemia and lymphoma. Leukemia is a disease of the white blood cells. The most common type of pediatric leukemia is acute lymphocytic leukemia. Other types of leukemia that occur less frequently in children are acute myeloid leukemia, and chronic myeloid leukemia. Lymphomas (Hodgkin and non-Hodgkin lymphoma) are the third most common cancer in children. Based on the characteristics and microscopic appearance of the cancer cell, the pediatric lymphomas are divided into Hodgkin Lymphoma and non-Hodgkin lymphoma. This Session Includes Pediatric Brain Tumor Models, Neurocutaneous Disorders, Neurofibromatosis, Primitive neuroectodermal tumor, Leukemia, Epigenetics in Pediatric Cancers, Pediatric Neurobiology and Proton Radiotherapy for Pediatric Brain Tumors.
- Track 10-1Psychosocial care
- Track 10-2Neurocutaneous disorders
- Track 10-3Primitive neuroectodermal tumor
- Track 10-4Epigenetics in pediatric cancers
- Track 10-5Pediatric neurobiology
- Track 10-6Emerging therapies in pediatric oncology
By optimizing our high-performance computing, we enable researchers to analyze and store massive amounts of genetic data more quickly than ever before. Through the cloud, medical professionals map tumor characterizations to the treatment database, which ultimately allows patients quicker access to better treatment. Researchers are now able to analyze a patient’s molecular data — a process that used to take 10 days — in six hours.
- Track 11-1Innovative high-performance computing
- Track 11-2Dell cloud technology
Clinical trials are used to determine the most effective and safest treatment for a disease. Each trial is aimed at improving survival rates or reducing side effects or late effects of treatment. It is important to understand that clinical trials are standard practice in cancer treatment for children, adolescents and young adults. While less than five percent of adults with cancer are enrolled in clinical trials, 60 percent of patients under age 29 diagnosed with cancer are enrolled in trials.
- Track 12-1The drug development and approval process
- Track 12-2Phases of clinical trials
- Track 12-3Types of clinical trials
- Track 12-4Treatment trials
- Track 12-5Prevention trials
- Track 12-6Screening and early-detection trials
- Track 12-7Diagnostic trials
- Track 12-8Genetics trials
- Track 12-9Quality-of-life / Supportive care trials